Delivery Order SPE2DB22D1106-SPE2DB24FFMP1
Award Date
9/12/24
Potential Completion Date
9/13/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Exforge 10-160 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $1,812.58 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 24, 2024. The contract has an ultimate completion date of October 25, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Exforge 5-160 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $1,812.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 7, 2023, with a completion date of June 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of various medical products and prescription medications. The contract, valued at $1,326.66, is a firm fixed-price delivery order that covers the provision of Exforge 5-320 mg tablets. The award has no set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Exforge 5-160 mg tablets. The contract has a ceiling value of $1,044.84 and a term running through February 24, 2022. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the primary...
This federal contract award is for the delivery of Exforge HCT 10-320-25 mg tablets to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $1,530.72, is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,742.16 firm fixed-price delivery order is for the supply of EXFORGE 5-160 MG Tablet 30S, a cardiovascular medication. The contract has an ultimate completion date of September 18, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,504.44 firm fixed-price delivery order is for the supply of EXFORGE 10-320 MG TABLET 30S, a cardiovascular medication. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of pharmaceutical products, specifically Exforge tablets. The delivery order, valued at $1,504.44, has a period of performance ending on September 16, 2024. It is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, which serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of medical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,771.89 firm fixed-price delivery order is for EXFORGE 10-160 MG TABLET 30S, a cardiovascular medication. This award is part of a broader $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,257.58 firm fixed-price delivery order is for the supply of EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...